Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Authors / Geoffrey Potjewyd

Geoffrey Potjewyd

The lion’s share of my PhD was spent in the lab, and though I mostly enjoyed it (mostly), what I particularly liked was the opportunity to learn about the latest breakthroughs in research. Communicating science to a wider audience allows me to scratch that itch without working all week only to find my stem cell culture has given up the ghost on the Friday (I’m not bitter). Fortunately for me, it turns out writing is actually fun – so by working for Texere I get to do it every day, whilst still being an active member of the clinical and research community.

  • Contributions

Peptide Pioneer

January 12, 2023

Robert Yu discusses the development of a new peptide treatment for dry eye disease

5 min read

Peptide Pioneer

Ora’s Ethos

January 25, 2023

David Bingaman and Sally Tucker discuss Ora’s involvement in ophthalmic therapeutic development

5 min read

Ora’s Ethos

Seeing Dementia Burden Clearly

January 10, 2022

How does cataract removal affect the risk of developing dementia?

1 min read

Seeing Dementia Burden Clearly

Overthrowing L-ORD

January 17, 2022

A hybrid approach to disease modeling identifies both a gene therapy and diabetes drug with the potential to tackle late-onset retinal degeneration

1 min read

Overthrowing L-ORD

Putting Vision on the Map

January 19, 2022

How multimodal MRI maps of the brain could help clinicians better understand visual field loss to support improved rehabilitation

1 min read

Putting Vision on the Map

Eyes on the Tries

February 4, 2022

On the eve of the Six Nations Championship, we interview Dan Morris, the Welsh Rugby Union Match Day Ophthalmologist on the tournament and his role in the team.

1 min read

Eyes on the Tries

OCT Under Pressure

February 7, 2022

Could optical coherence tomography ever replace current – highly invasive – intracranial pressure monitoring methods?

1 min read

OCT Under Pressure
Sponsored

A Rare Discovery

February 15, 2022

Is the Campana cell a new class of retinal neuron?

1 min read

A Rare Discovery

Vision Research in the Spotlight

February 16, 2022

The leadership team of ARVO give us an insight into how the organization has grown in challenging times

1 min read

Vision Research in the Spotlight

Rare and Important

February 28, 2022

Kapil Bharti of NEI explains the importance of rare disease research and his progress for Rare Disease Day 2022

1 min read

Rare and Important

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: